150 related articles for article (PubMed ID: 18762157)
1. Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective.
Sacks LV; Behrman RE
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S93-100. PubMed ID: 18762157
[TBL] [Abstract][Full Text] [Related]
2. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
Lienhardt C; Davies G
Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
[TBL] [Abstract][Full Text] [Related]
3. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
Lienhardt C; Vernon A; Raviglione MC
Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
[TBL] [Abstract][Full Text] [Related]
4. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
Rivers EC; Mancera RL
Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542
[TBL] [Abstract][Full Text] [Related]
5. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
6. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis.
Lalloo UG; Naidoo R; Ambaram A
Curr Opin Pulm Med; 2006 May; 12(3):179-85. PubMed ID: 16582672
[TBL] [Abstract][Full Text] [Related]
8. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
10. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
11. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Gubkina MF; Ershova NG
Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
[TBL] [Abstract][Full Text] [Related]
12. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
Mitrzyk BM
Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
[TBL] [Abstract][Full Text] [Related]
13. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
Showalter HD; Denny WA
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151
[TBL] [Abstract][Full Text] [Related]
14. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
[TBL] [Abstract][Full Text] [Related]
15. Models and approaches for anti-TB drug testing.
Yasinskaya Y; Sacks L
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):823-31. PubMed ID: 21810054
[TBL] [Abstract][Full Text] [Related]
16. New drugs fight TB.
AIDS Patient Care STDS; 2000 Sep; 14(9):522. PubMed ID: 11051641
[No Abstract] [Full Text] [Related]
17. Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.
Tabarsi P; Baghaei P; Jalali S; Farnia P; Chitsaz E; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Scand J Infect Dis; 2009; 41(1):10-3. PubMed ID: 19037820
[TBL] [Abstract][Full Text] [Related]
18. Rising standards for tuberculosis drug development.
Balganesh TS; Alzari PM; Cole ST
Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
[TBL] [Abstract][Full Text] [Related]
19. Sustainable tuberculosis drug development.
Wallis RS
Clin Infect Dis; 2013 Jan; 56(1):106-13. PubMed ID: 23042970
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other.
Colebunders R; Worodria W; Jones-López E; Joloba M; Apers L; Ellner J
Trop Med Int Health; 2008 Sep; 13(9):1204-7. PubMed ID: 18664238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
